Portal de Periódicos da CAPES

Awareness, treatment and control of hypertension, dyslipidaemia and diabetes mellitus in an Iranian population: the IHHP study.

2010; World Health Organization; Volume: 15; Issue: 6 Linguagem: Inglês

1687-1634

Shahin Shirani, Roya Kelishadi, Nizal Sarrafzadegan, Alireza Khosravi, Gh Sadri, Amani Abdelgader Mohammed Abdelgader, Seyed Taghi Heidari, M.A. Ramezani,

Liver Disease Diagnosis and Treatment

We used data from the baseline survey from the Isfahan Healthy Heart Programme to determine the prevalence of hypertension, dyslipidaemia and diabetes among a representative samples of 12,514 adults living in 3 cities in the Islamic Republic of Iran. The prevalence of hypertension, dyslipidaemia and diabetes was 17.3%, 66.3% and 5.6% respectively. Awareness, treatment and control of hypertension were 40.3%, 35.3%, and 9.1% respectively. The rates for dyslipidaemia were 14.4%, 7.1% and 6.5% respectively, and 54.6% of diabetics were aware of their disease and 46.2% were under treatment.